209 related articles for article (PubMed ID: 33597243)
1. Repression of Wnt/β-catenin signaling by SOX9 and Mastermind-like transcriptional coactivator 2.
Sinha A; Fan VB; Ramakrishnan AB; Engelhardt N; Kennell J; Cadigan KM
Sci Adv; 2021 Feb; 7(8):. PubMed ID: 33597243
[TBL] [Abstract][Full Text] [Related]
2. SOX9 and TCF transcription factors associate to mediate Wnt/β-catenin target gene activation in colorectal cancer.
Ramakrishnan AB; Burby PE; Adiga K; Cadigan KM
J Biol Chem; 2023 Jan; 299(1):102735. PubMed ID: 36423688
[TBL] [Abstract][Full Text] [Related]
3. SOX9/NFIA promotes human ovarian cancer metastasis through the Wnt/β-catenin signaling pathway.
Lu R; Tang P; Zhang D; Lin S; Li H; Feng X; Sun M; Zhang H
Pathol Res Pract; 2023 Aug; 248():154602. PubMed ID: 37315400
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of SOX9 promotes the self-renewal and tumorigenicity of cervical cancer through activating the Wnt/β-catenin signaling pathway.
Feng Q; Cui N; Li S; Cao J; Chen Q; Wang H
FASEB J; 2023 Oct; 37(10):e23174. PubMed ID: 37668416
[TBL] [Abstract][Full Text] [Related]
5. SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.
Wang H; He L; Ma F; Regan MM; Balk SP; Richardson AL; Yuan X
J Biol Chem; 2013 Mar; 288(9):6478-87. PubMed ID: 23306204
[TBL] [Abstract][Full Text] [Related]
6. SOX9 regulated proliferation and apoptosis of human lung carcinoma cells by the Wnt/β-catenin signaling pathway.
Guo YZ; Xie XL; Fu J; Xing GL
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4898-4907. PubMed ID: 30070325
[TBL] [Abstract][Full Text] [Related]
7. Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus.
Topol L; Chen W; Song H; Day TF; Yang Y
J Biol Chem; 2009 Jan; 284(5):3323-3333. PubMed ID: 19047045
[TBL] [Abstract][Full Text] [Related]
8. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
[TBL] [Abstract][Full Text] [Related]
9. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival.
Alves-Guerra MC; Ronchini C; Capobianco AJ
Cancer Res; 2007 Sep; 67(18):8690-8. PubMed ID: 17875709
[TBL] [Abstract][Full Text] [Related]
10. Odd-skipped related 1 inhibits lung cancer proliferation and invasion by reducing Wnt signaling through the suppression of SOX9 and β-catenin.
Wang Y; Lei L; Zheng YW; Zhang L; Li ZH; Shen HY; Jiang GY; Zhang XP; Wang EH; Xu HT
Cancer Sci; 2018 Jun; 109(6):1799-1810. PubMed ID: 29660200
[TBL] [Abstract][Full Text] [Related]
11. SOX9 Overexpression Promotes Glioma Metastasis via Wnt/β-Catenin Signaling.
Liu H; Liu Z; Jiang B; Peng R; Ma Z; Lu J
Cell Biochem Biophys; 2015 Sep; 73(1):205-12. PubMed ID: 25716338
[TBL] [Abstract][Full Text] [Related]
12. Wnt signaling in ovarian development inhibits Sf1 activation of Sox9 via the Tesco enhancer.
Bernard P; Ryan J; Sim H; Czech DP; Sinclair AH; Koopman P; Harley VR
Endocrinology; 2012 Feb; 153(2):901-12. PubMed ID: 22128028
[TBL] [Abstract][Full Text] [Related]
13. BMP-2-enhanced chondrogenesis involves p38 MAPK-mediated down-regulation of Wnt-7a pathway.
Jin EJ; Lee SY; Choi YA; Jung JC; Bang OS; Kang SS
Mol Cells; 2006 Dec; 22(3):353-9. PubMed ID: 17202865
[TBL] [Abstract][Full Text] [Related]
14. Loss of β-catenin promotes chondrogenic differentiation of aortic valve interstitial cells.
Fang M; Alfieri CM; Hulin A; Conway SJ; Yutzey KE
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2601-8. PubMed ID: 25341799
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of SOX9 alleviates tracheal fibrosis through the Wnt/β-catenin signaling pathway.
Gu L; Li A; Lin J; Gan Y; He C; Xiao R; Liao J; Li Y; Guo S
J Mol Med (Berl); 2022 Nov; 100(11):1659-1670. PubMed ID: 36192639
[TBL] [Abstract][Full Text] [Related]
16. LRP6 transduces a canonical Wnt signal independently of Axin degradation by inhibiting GSK3's phosphorylation of beta-catenin.
Cselenyi CS; Jernigan KK; Tahinci E; Thorne CA; Lee LA; Lee E
Proc Natl Acad Sci U S A; 2008 Jun; 105(23):8032-7. PubMed ID: 18509060
[TBL] [Abstract][Full Text] [Related]
17. Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex.
Li VS; Ng SS; Boersema PJ; Low TY; Karthaus WR; Gerlach JP; Mohammed S; Heck AJ; Maurice MM; Mahmoudi T; Clevers H
Cell; 2012 Jun; 149(6):1245-56. PubMed ID: 22682247
[TBL] [Abstract][Full Text] [Related]
18. SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt/ß-catenin signaling.
Prévostel C; Rammah-Bouazza C; Trauchessec H; Canterel-Thouennon L; Busson M; Ychou M; Blache P
Oncotarget; 2016 Dec; 7(50):82228-82243. PubMed ID: 27429045
[TBL] [Abstract][Full Text] [Related]
19. Centrosomes are required for proper β-catenin processing and Wnt response.
Vora SM; Fassler JS; Phillips BT
Mol Biol Cell; 2020 Aug; 31(17):1951-1961. PubMed ID: 32583737
[TBL] [Abstract][Full Text] [Related]
20. Identification of targets of the Wnt pathway destruction complex in addition to beta-catenin.
Kim NG; Xu C; Gumbiner BM
Proc Natl Acad Sci U S A; 2009 Mar; 106(13):5165-70. PubMed ID: 19289839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
